Logo image of SRP.PA

SHOWROOMPRIVE (SRP.PA) Stock Fundamental Analysis

Europe - EPA:SRP - FR0013006558 - Common Stock

0.445 EUR
-0.01 (-1.11%)
Last: 10/23/2025, 1:51:25 PM
Fundamental Rating

2

Overall SRP gets a fundamental rating of 2 out of 10. We evaluated SRP against 53 industry peers in the Specialty Retail industry. SRP has a bad profitability rating. Also its financial health evaluation is rather negative. SRP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

SRP had negative earnings in the past year.
SRP had a positive operating cash flow in the past year.
Of the past 5 years SRP 4 years were profitable.
In the past 5 years SRP always reported a positive cash flow from operatings.
SRP.PA Yearly Net Income VS EBIT VS OCF VS FCFSRP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -9.85%, SRP is doing worse than 75.47% of the companies in the same industry.
SRP has a worse Return On Equity (-24.37%) than 71.70% of its industry peers.
Industry RankSector Rank
ROA -9.85%
ROE -24.37%
ROIC N/A
ROA(3y)-3.22%
ROA(5y)-0.11%
ROE(3y)-7.98%
ROE(5y)-0.56%
ROIC(3y)N/A
ROIC(5y)N/A
SRP.PA Yearly ROA, ROE, ROICSRP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

SRP's Gross Margin of 36.82% is in line compared to the rest of the industry. SRP outperforms 56.60% of its industry peers.
SRP's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for SRP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.56%
GM growth 5Y3.86%
SRP.PA Yearly Profit, Operating, Gross MarginsSRP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

SRP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SRP remains at a similar level compared to 1 year ago.
SRP has more shares outstanding than it did 5 years ago.
SRP has a better debt/assets ratio than last year.
SRP.PA Yearly Shares OutstandingSRP.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SRP.PA Yearly Total Debt VS Total AssetsSRP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

A Debt/Equity ratio of 0.15 indicates that SRP is not too dependend on debt financing.
SRP has a Debt to Equity ratio of 0.15. This is amongst the best in the industry. SRP outperforms 92.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC6.25%
SRP.PA Yearly LT Debt VS Equity VS FCFSRP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.82 indicates that SRP may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.82, SRP is doing worse than 86.79% of the companies in the same industry.
A Quick Ratio of 0.47 indicates that SRP may have some problems paying its short term obligations.
SRP has a worse Quick ratio (0.47) than 64.15% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.47
SRP.PA Yearly Current Assets VS Current LiabilitesSRP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

2

3. Growth

3.1 Past

SRP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -8321.43%.
Looking at the last year, SRP shows a decrease in Revenue. The Revenue has decreased by -4.53% in the last year.
SRP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.98% yearly.
EPS 1Y (TTM)-8321.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1346.57%
Revenue 1Y (TTM)-4.53%
Revenue growth 3Y-3.7%
Revenue growth 5Y0.98%
Sales Q2Q%86.92%

3.2 Future

The Earnings Per Share is expected to grow by 20.20% on average over the next years. This is a very strong growth
SRP is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.02% yearly.
EPS Next Y21.05%
EPS Next 2Y26.7%
EPS Next 3Y20.2%
EPS Next 5YN/A
Revenue Next Year-16.36%
Revenue Next 2Y-7.26%
Revenue Next 3Y-4.02%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SRP.PA Yearly Revenue VS EstimatesSRP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
SRP.PA Yearly EPS VS EstimatesSRP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SRP. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SRP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SRP.PA Price Earnings VS Forward Price EarningsSRP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SRP.PA Per share dataSRP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

SRP's earnings are expected to grow with 20.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.7%
EPS Next 3Y20.2%

More info and screens

0

5. Dividend

5.1 Amount

SRP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SHOWROOMPRIVE

EPA:SRP (10/23/2025, 1:51:25 PM)

0.445

-0.01 (-1.11%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)10-16 2025-10-16
Earnings (Next)03-11 2026-03-11/amc
Inst Owners0.31%
Inst Owner ChangeN/A
Ins Owners56.29%
Ins Owner ChangeN/A
Market Cap52.98M
Revenue(TTM)646.46M
Net Income(TTM)-39689000
Analysts50
Price Target0.59 (32.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-8%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-400%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.08
P/FCF N/A
P/OCF 3.72
P/B 0.33
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.35
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.12
OCFY26.88%
SpS5.43
BVpS1.37
TBVpS-0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.85%
ROE -24.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.82%
FCFM N/A
ROA(3y)-3.22%
ROA(5y)-0.11%
ROE(3y)-7.98%
ROE(5y)-0.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.56%
GM growth 5Y3.86%
F-Score5
Asset Turnover1.6
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 145.9%
Cap/Sales 3.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.47
Altman-Z N/A
F-Score5
WACC6.25%
ROIC/WACCN/A
Cap/Depr(3y)90%
Cap/Depr(5y)82.36%
Cap/Sales(3y)2.07%
Cap/Sales(5y)1.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8321.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1346.57%
EPS Next Y21.05%
EPS Next 2Y26.7%
EPS Next 3Y20.2%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.53%
Revenue growth 3Y-3.7%
Revenue growth 5Y0.98%
Sales Q2Q%86.92%
Revenue Next Year-16.36%
Revenue Next 2Y-7.26%
Revenue Next 3Y-4.02%
Revenue Next 5YN/A
EBIT growth 1Y-3157.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year34.78%
EBIT Next 3Y25.99%
EBIT Next 5YN/A
FCF growth 1Y-705.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.34%
OCF growth 3Y-26.69%
OCF growth 5YN/A